Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules
Authors:
- Marco PicardiMarco Picardi
- Claudia GiordanoCGClaudia Giordano
- Fabio TrastulliFTFabio Trastulli
- Aldo LeoneALAldo Leone
- Roberta Della PepaRPRoberta Della Pepa
- Novella PuglieseNPNovella Pugliese
- Rossella IulaRIRossella Iula
- Giuseppe Delle CaveGCGiuseppe Delle Cave
- Maria Gabriella RascatoMRMaria Gabriella Rascato
- Maria EspositoMEMaria Esposito
- Elena VigliarElena Vigliar
- Giancarlo TronconeGTGiancarlo Troncone
Open Access
Abstract
Contrast-enhanced ultrasonography (CEUS) use for detecting lymphoma in the spleen was questioned because of the risk of its inadequate diagnostic accuracy. The aim of the present study was to validate CEUS exam for the identification of spleen involvement by lymphoma in patients at risk. A total of 260 nodules from the spleens of 77 patients with lymph node biopsy-proven non-Hodgkin lymphoma (NHL; n = 44) or Hodgkin lymphoma (HL; n = 33) at staging (n = 56) or follow-up (n = 21) were collected in a hematology Italian center and retrospectively analyzed. Nodules were classified as malignant lymphoma if ≥0.5 cm (long axis) with arterial phase isoen-hancement and early (onset <60 s after contrast agent injection) wash-out of marked (≤120 s after contrast agent injection) degree. Other perfusional combinations at CEUS scans qualified lesions as benign or inconclusive. Diagnostic reference standard was clinical laboratory imaging monitoring for 230 nodules, and/or histology for 30 nodules. The median nodule size was 1.5 cm (range 0.5–7 cm). According to the reference standard, 204 (78%) nodules were lymphomas (aggressive-NHL (a-NHL), 122; classic-HL (c-HL), 65; indolent (i)-NHL, 17) and 56 (22%) were benign (inflammation, infection, and/or mesenchymal) lesions. Sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy of CEUS for detecting lymphoma in the spleen were 95%, 100%, 100%, 85%, and 96%, respectively. Marked wash-out range of 55–90 s (median, 74 s), 92–120 s (median, 100 s), and 101–120 s (median, 114.5 s) was 100%, 96.6%, and 77% predictive of a-NHL, c-HL, and i-NHL splenic nodular infiltration, respectively. The CEUS perfusional pattern of arterial phase isoenhancement with early wash-out of marked degree was highly accurate for the detection of lymphomatous invasion of spleen in patients at risk, enabling its use for a confident non-invasive diagnosis.Keywords
This publication has 23 references indexed in Scilit:
- SIE, SIES, GITMO revised guidelines for the management of follicular lymphomaAmerican Journal of Hematology, 2012
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsBlood, 2011
- How I diagnose and treat splenic lymphomasBlood, 2011
- Fused FDG–PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleenAnnals of Oncology, 2010
- FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin DiseaseRadioGraphics, 2010
- Contrast-enhanced Harmonic Compound US of the Spleen to Increase Staging Accuracy in Patients with Hodgkin Lymphoma: A Prospective StudyRadiology, 2009
- Lymphoma of the SpleenSeminars in Ultrasound, CT and MRI, 2007
- Angiogenesis in nodal B cell lymphomas: a high throughput studyJournal of Clinical Pathology, 2006
- Randomized Comparison of Power Doppler Ultrasound-Directed Excisional Biopsy With Standard Excisional Biopsy for the Characterization of Lymphadenopathies in Patients With Suspected LymphomaJournal of Clinical Oncology, 2004
- The use of “overall accuracy” to evaluate the validity of screening or diagnostic testsJournal of General Internal Medicine, 2004